Becker Capital Management Inc Astrazeneca PLC Transaction History

Becker Capital Management Inc

$3.04 Billion
Q3 2024

A detailed history of Becker Capital Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Becker Capital Management Inc holds 377,273 shares of AZN stock, worth $25 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

377,273

Previous 379,982 0.71%

Holding current value

$25 Million

Previous $29.6 Million 0.8%

% of portfolio

0.97%

Previous 1.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$76.67 - $87.62 $207,699 - $237,362	-2,709 Reduced 0.71%	377,273 $29.4 Million
Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $344,806 - $417,163	-5,161 Reduced 1.34%	379,982 $29.6 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $206,342 - $235,216	3,381 Added 0.89%	385,143 $26.1 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $409,526 - $458,425	-6,617 Reduced 1.7%	381,762 $25.7 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $448,826 - $496,235	-6,921 Reduced 1.75%	388,379 $26.3 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $458,260 - $496,934	-6,555 Reduced 1.63%	395,300 $28.3 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $961,585 - $1.09 Million	-15,227 Reduced 3.65%	401,855 $27.9 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $152,113 - $197,654	-2,806 Reduced 0.67%	417,082 $28.3 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $3.73 Million - $9.54 Million	-70,285 Reduced 14.34%	419,888 $23 Million
Q2 2022 Aug 04, 2022	SELL	$59.26 - $71.14 $3.7 Million - $4.44 Million	-62,464 Reduced 11.3%	490,173 $32.4 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $1.77 Million - $2.14 Million	-31,842 Reduced 5.45%	552,637 $36.7 Million
Q4 2021 Feb 08, 2022	SELL	$54.02 - $63.83 $622,094 - $735,066	-11,516 Reduced 1.93%	584,479 $34 Million
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $64,282 - $70,334	1,157 Added 0.19%	595,995 $35.8 Million
Q2 2021 Aug 12, 2021	SELL	$48.42 - $60.18 $464,202 - $576,945	-9,587 Reduced 1.59%	594,838 $35.6 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $134,547 - $155,317	-2,853 Reduced 0.47%	604,425 $30.1 Million
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $587,819 - $702,912	-12,115 Reduced 1.96%	607,278 $30.4 Million
Q3 2020 Nov 09, 2020	SELL	$53.07 - $61.1 $1.63 Million - $1.87 Million	-30,658 Reduced 4.72%	619,393 $33.9 Million
Q2 2020 Aug 11, 2020	SELL	$43.1 - $55.31 $6.32 Million - $8.11 Million	-146,631 Reduced 18.41%	650,051 $34.4 Million
Q1 2020 May 07, 2020	SELL	$37.79 - $51.33 $11.9 Million - $16.2 Million	-315,116 Reduced 28.34%	796,682 $35.6 Million
Q4 2019 Feb 11, 2020	SELL	$42.46 - $50.46 $6.96 Million - $8.27 Million	-163,825 Reduced 12.84%	1,111,798 $55.4 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $1.66 Million - $1.88 Million	-41,283 Reduced 3.13%	1,275,623 $56.9 Million
Q2 2019 Aug 08, 2019	SELL	$37.28 - $41.68 $240,903 - $269,336	-6,462 Reduced 0.49%	1,316,906 $54.4 Million
Q1 2019 May 08, 2019	SELL	$35.49 - $43.02 $1.87 Million - $2.26 Million	-52,619 Reduced 3.82%	1,323,368 $53.5 Million
Q4 2018 Feb 04, 2019	SELL	$36.86 - $41.49 $3.62 Million - $4.08 Million	-98,335 Reduced 6.67%	1,375,987 $52.3 Million
Q3 2018 Nov 05, 2018	SELL	$34.76 - $39.72 $1.64 Million - $1.87 Million	-47,067 Reduced 3.09%	1,474,322 $58.3 Million
Q2 2018 Aug 03, 2018	SELL	$34.55 - $37.05 $2.36 Million - $2.53 Million	-68,243 Reduced 4.29%	1,521,389 $53.4 Million
Q1 2018 May 07, 2018	BUY	$32.97 - $36.63 $2.13 Million - $2.37 Million	64,715 Added 4.24%	1,589,632 $55.6 Million
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $831,291 - $900,975	25,905 Added 1.73%	1,524,917 $52.9 Million
Q3 2017 Nov 02, 2017	BUY	$28.96 - $34.0 $2.92 Million - $3.43 Million	100,835 Added 7.21%	1,499,012 $50.8 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,398,177	1,398,177 $47.7 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.

Account

Becker Capital Management Inc Astrazeneca PLC Transaction History